Figure 2.

Schematic illustration of the different 2D NSs and their advantages for versatile cancer therapeutics. BP (adapted from Reference [17], Materials Horizons, published by The Royal Society of Chemistry, 2017), Ti₃C₂ (adapted with permission from Reference [18], Journal of Molecular Liquids, published by Elsevier, 2020), MoS₂ (adapted with permission from Reference [19], Langmuir, published by American Chemical Society, 2017), WS₂ (adapted from Reference [20] under the terms of the Creative Commons Attribution 4.0 International License), and LDHs (adapted from Reference [21], RSC Advances, published by The Royal Society of Chemistry, 2014).